Date published: 2026-5-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

L-type Ca++ CP γ8 Activators

Chemical activators of L-type Ca++ CP γ8, such as Bay K 8644 and its (S)-(-) enantiomer, directly target and enhance the activity of L-type calcium channels, to which the CACNG8 protein is closely related. These activators increase the probability of channel opening, thus boosting calcium influx through the channels. FPL 64176 and CGP 28392 also target these channels, but through different mechanisms, with FPL 64176 being a non-dihydropyridine activator and CGP 28392 being a dihydropyridine compound, both result in an increased function of CACNG8. (RS)-Roscovitine, although primarily a cyclin-dependent kinase inhibitor, has been shown to have a similar effect on L-type calcium channel activity, suggesting a possible enhancement of CACNG8 activity.

Other compounds, like Anisodamine and Neostigmine, operate through cholinergic pathways that can indirectly affect L-type calcium channel activity. Galantamine, by enhancing nicotinic acetylcholine receptor-mediated responses, can also lead to an upsurge in calcium influx through these channels, thereby increasing the activity of CACNG8. Compounds such as Caffeine and Theophylline act by releasing intracellular calcium stores or increasing intracellular cAMP levels, respectively, which can subsequently lead to the phosphorylation and enhancement of L-type calcium channel function. Forskolin, by increasing cAMP, could likewise enhance the channel activity and thus the function of CACNG8. Nitrendipine, interestingly, at specific non-blocking concentrations can have an enhancing effect on these channels, which could contribute to the activation of CACNG8. These selected chemicals, by various interactions with the L-type calcium channels and related cellular signaling pathways, can functionally activate the CACNG8 protein.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

(±)-Bay K 8644

71145-03-4sc-203324
sc-203324A
sc-203324B
1 mg
5 mg
50 mg
$84.00
$196.00
$817.00
(0)

Bay K 8644 acts as an L-type calcium channel agonist, which can directly increase the open probability of the channels associated with CACNG8, resulting in increased calcium influx.

FPL-64176

120934-96-5sc-201491
5 mg
$83.00
1
(1)

FPL 64176 is a non-dihydropyridine calcium channel activator, which can enhance the function of L-type calcium channels, potentially increasing the activity of the CACNG8 subunit.

Roscovitine

186692-46-6sc-24002
sc-24002A
1 mg
5 mg
$94.00
$265.00
42
(2)

(RS)-Roscovitine, a cyclin-dependent kinase inhibitor, has been shown to increase L-type calcium channel activity, which could in turn enhance CACNG8 function.

Galanthamine

357-70-0sc-218556
10 mg
$320.00
(0)

Galanthamine enhances nicotinic acetylcholine receptor-mediated responses, which can increase calcium influx through L-type channels and thereby activate CACNG8.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

Caffeine can cause the release of intracellular calcium stores and potentially enhance L-type calcium channel activity, indirectly activating CACNG8.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$32.00
$85.00
6
(0)

Theophylline increases intracellular cAMP levels, which could lead to phosphorylation and activation of L-type calcium channels, including those associated with CACNG8.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylate cyclase, increasing cAMP levels, which can result in enhanced L-type calcium channel activity and consequent activation of CACNG8.

Nitrendipine

39562-70-4sc-201466
sc-201466A
sc-201466B
50 mg
100 mg
500 mg
$109.00
$160.00
$458.00
6
(1)

Nitrendipine, while commonly known as an L-type calcium channel blocker, at specific concentrations can paradoxically enhance channel activity, potentially activating CACNG8.